News

A person using a virtual reality lens
By  Adam Ang 06:09 am October 17, 2024
A $1.9 million government grant-backed project will be the first to use VR for trauma support in rural indigenous communities.  
A doctor holding a digital tablet showing a patient their bone X-ray
By  Adam Ang 06:01 am October 17, 2024
Up to 16 million senior Indonesians are reportedly at risk of osteoporosis.  
PursueCare prescription digital therapeutics apps
By  Anthony Vecchione 05:34 pm October 16, 2024
The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.
Person reviewing data on a cell phone screen
By  Anthony Vecchione 12:51 pm October 16, 2024
The seed funding will be used to grow the company's team and develop its technology.
Healthcare provider on a computer screen talking to someone sitting at a desk
By  Jessica Hagen 10:54 am October 16, 2024
The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.
Heart monitor screen
By  Anthony Vecchione 01:12 pm October 15, 2024
The algorithms are used to detect valvular heart disease.
Healthcare provider in a pharmacy
By  Jessica Hagen 11:57 am October 15, 2024
The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.
Five people sitting around a table speaking with each other
By  Jessica Hagen 08:00 am October 15, 2024
The AHA and MDisrupt will also co-develop a platform to enable expert referrals and disseminate evidence-based science to healthcare technology innovators. 
Patient looking at medical records on smart phone
By  Anthony Vecchione 03:23 pm October 14, 2024
The alliance streamlines verification of patient-driven record demands to Selfii's patient data network.  
Two people holding another person while standing over them
By  Anthony Vecchione 01:32 pm October 14, 2024
The company will be subject to a 12-month follow-up review period to assure that it does not fall below NYSE standards.